Visit https://www.peervoice.com/FKD860 to view the entire programme with slides. After completing “Diana N. Ionescu, MD - To Target We Need to Test: Why and How to Identify Folate Receptor Alpha-Positive Ovarian Cancer”, participants will be able to: Use the clinical data for folate receptor alpha (FRɑ)-targeted therapies for ovarian cancer to evaluate the need for establishing FRɑ status; Describe the immunohistochemical characteristics of FRɑ-positive ovarian cancer; and Apply guideline recommendations for FRɑ testing and targeted treatment in patients with ovarian cancer.